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Introduction: Fragmented QRS (fQRS) complex on routine 12-lead electrocardio-
gram (ECG) predicts adverse outcomes in patients with cardiovascular diseases. In 
addition, it has been found to be associated with subclinical myocardial dysfunction 
in chronic diseases. We sought to investigate the relationship between the presence 
of fQRS with the myocardial functions in individuals free from known systemic car-
diovascular diseases.
Methods: In a case-control study, we evaluated normal individuals from March 2017 
to February 2018. All participants underwent a 2-dimensional transthoracic echo-
cardiographic examination using tissue Doppler imaging (TDI) and speckle-tracking 
echocardiography. In addition, all participants were examined using a 12-lead surface 
ECG, and patients with fQRS and a group of age- and sex-matched controls without 
fQRS were enrolled in our study.
Results: The patients' mean age was 40.3 ± 10.7 and 35.4 ± 11.2 years in fQRS-
positive and fQRS-negative groups, respectively (P = .110). Patients with fQRS had 
significantly lower values of apical left ventricular global longitudinal strain (LV 
GLS) in 2-chamber (16.9 ± 2.5 vs. 20.5 ± 3.3, P < .001), 4-chamber (16.9 ± 3.4 vs. 
20.1 ± 3, P = .001), LAX views (17.7 ± 2.8 vs. 20.8 ± 3.5, P = .001), and averaged LV 
GLS (17 ± 2.6 vs. 20.4 ± 2.7, P < .001) values compared to patients without fQRS. 
In a multivariate analysis, averaged LV GLS and smoking history were independent 
predictors for positive fQRS.
Conclusion: The presence of fQRS on 12-lead ECG in healthy population was associ-
ated with lower values of LV GLS compared to normal individuals without fQRS.
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1  | INTRODUC TION
Fragmented QRS (fQRS) complex is detected in a 12-lead electrocar-
diogram (ECG), which has enormously been used for the prediction 
of cardiovascular outcomes.1 The fQRS indicates altered ventricu-
lar depolarization caused by myocardial fibrosis and scar in patients 
with ischemic heart diseases.2‒5 It is not only observed in patients 
with coronary artery diseases, but is also found in cardiomyopa-
thies, structural heart diseases, heart rhythm disturbances, cardiac 
sarcoidosis, and even healthy population.1,6‒8 The fQRS has been 
found to be a marker of clinical outcomes in different cardiovascular 
diseases. Several studies have shown that the fQRS is a predictor 
of sudden cardiac death in patients with cardiomyopathy and heart 
failure,6,9 a predictor of cardiac events and mortality in patients with 
coronary artery disease,10‒12 a marker for nonresponsiveness to car-
diac resynchronization therapy in heart failure patients with ventric-
ular dyssynchrony,13 a prognostic marker for dysrhythmia in patients 
with Brugada syndrome,14 and short-term prognosis of patients un-
dergoing transcatheter aortic valve implantation.15
The standard 12-lead ECG can be suggestive of abnormal find-
ings during echocardiographic findings and patients should be reg-
ularly followed up.16 In addition to the prognostic value of fQRS in 
patients with cardiovascular diseases, it has also been found to be 
associated with subclinical myocardial dysfunction in patients with 
coronary artery disease,17 diabetes mellitus,18 and chronic kidney 
disease.19 The assessment of myocardial tissue by conventional 
echocardiography is load- and angle-dependent, but 2-dimensional 
speckle-tracking echocardiography (2D-STE) lacks such a limitation 
for the evaluation of myocardial mechanics.20‒23 Although left ven-
tricular ejection fraction (LVEF) is commonly used for the evaluation 
of LV function, 2D-STE parameters, mainly global longitudinal strain 
(GLS), have been found to be a feasible modality for examination of 
left ventricle (LV) function.24
In this case-control study, we sought to determine the relation-
ship between the presence of fQRS in apparently healthy individuals 
without cardiovascular diseases and preserved LVEF and subclinical 
LV dysfunction using 2-dimensional transthoracic echocardiography 
(2D-TTE) with the implementation of tissue Doppler imaging (TDI) 
and speckle-tracking echocardiography.
2  | METHODS AND MATERIAL S
2.1 | Study protocol and population
In a case-control study, we prospectively enrolled normal individu-
als with or without fQRS on their 12-lead surface ECG at rest, from 
March 2017 to February 2018 in Urmia city, Iran. All participants 
underwent a comprehensive 2D-TTE examination using TDI and STE 
modalities to evaluate the structural and functional features of their 
heart. The study was approved by the institutional review board in 
Seyyed-al-Shohada Heart Center and the local ethics committee 
of Urmia University of Medical Sciences, Urmia, West Azerbaijan 
province, Iran. In addition, informed consent was obtained from all 
participants at baseline.
Twenty-six consecutive patients who visited our outpatient clinic 
with positive fQRS were recruited into this study. In addition, 28 
age- and sex-matched individuals who had negative fQRS in baseline 
ECG were also enrolled. Inclusion criteria included healthy individu-
als who were referred to be evaluated for probable cardiac diseases 
before military service entrance, employment in governmental or-
ganizations, a requirement for insurance validity, and participation 
in sport events. In addition, some people who visited our outpatient 
clinic for palpitation and atypical chest pain with a low probability 
of coronary artery diseases whose stress tests and/or cardiac scans 
had been negative for any ischemic heart diseases. Exclusion criteria 
included patients with known history of coronary artery diseases, 
any signs of ischemic heart diseases in stress tests and cardiac scan, 
heart failure, diabetes mellitus, hypertension, hypercholesterolemia, 
LVEF lower than 55%, any significant valvular diseases (ie, greater 
than mild involvement), any congenital heart diseases, atrioven-
tricular conduction abnormalities, QRS duration longer than 120 
milliseconds, pulmonary arterial hypertension, chronic obstructive 
pulmonary diseases, consumption of any medications for chronic 
diseases, and bundle branch block in ECG trace.
2.2 | Electrocardiographic examination
All participants were examined by a 12-lead surface ECG at rest 
(0.5 Hz to 150 Hz, 25 mm/s, 10 mm/mV). ECGs were analyzed by two 
clinicians who were blinded to the impression of cases. In case of 
disagreement, the mutual agreement was used to reach a final diag-
nosis. The fQRS was defined as the detection of RSRʹ pattern, which 
can be observed as follows: (i) an additional R wave; (ii) a notching 
in nadir of the S wave; (iii) a notching of the R wave; (iv) Rʹ wave >1 
millimeter; and (v) the presence of fragmentation, more than one Rʹ 
wave, in two contiguous ECG leads.1,25
2.3 | Echocardiographic examination
All echocardiographic measurements were performed based on the 
recommendations of the American Society of Echocardiography and 
the European Association of Cardiovascular Imaging,26 using an ul-
trasound scanner (Vivid S6). A 2D-TTE was used to evaluate the pres-
ence of any structural heart diseases, valvular and congenital heart 
diseases. The LVEF was also measured using the biplane Simpson's 
method. All echocardiographic examinations were carried out by a 
single echocardiographer in our echocardiography laboratory.
A standard M-mode, 2D, and color-coded TDI images were ob-
tained during breath hold, as an average of three consecutive beats. 
The TDI was provided from the annular and septal mitral valve area. 
The harmonic image recordings of apical and short-axis views at mi-
tral valve and papillary muscle levels (30-90 frames/second) were 
provided and stored to be analyzed offline using AFI (automated 
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functional imaging) software. The left ventricular GLS (LV GLS) was 
calculated by averaging apical 4-chamber, 2-chamber, and LAX views. 
Based on a meta-analysis,27 the ranges of GLS in normal population is 
15.9% to 22.1%; therefore, the GLS was considered abnormal when 
it was smaller than 16 in our cohort. The evaluation of LV diastolic 
dysfunction was also performed using the latest American Society 
of Echocardiography guideline for LV diastolic dysfunction as well.28
2.4 | Statistical analysis
All variables are presented as mean ± standard deviation, and t test 
was used to compare continuous variables between groups. Chi-
squared tests or Fisher's exact test was implemented for comparing 
categorical variables as appropriate. A multivariate regression analysis 
was conducted to evaluate the relationship between fQRS and LV GLS 
values. The model was also adjusted for age, gender, smoking history, 
QRS duration, QT interval corrected for heart rate, body mass index, 
and total cholesterol level. Adjusted odds ratios (ORs) and correspond-
ing confidence intervals (CIs) were reported. A two-tailed P < .05 was 
considered statistically significant. All statistical analyses were per-
formed using the IBM SPSS software version 22.0 (IBM, Armonk).
3  | RESULTS
The patients' mean age was 40.3 ± 10.7 and 35.4 ± 11.2 years in 
fQRS-positive and fQRS-negative groups, respectively (P = .110). 
The number of smokers was significantly higher in positive fQRS 
compared to negative fQRS group (30.8% vs 7.1%; P = .026). The 
half of patients with fQRS (13%, 50%) had fQRS in less than three 
leads and others had fQRS in three or more than three leads. Fifteen 
patients (57.7% of fQRS patients) had fQRS in inferior leads, five pa-
tients (19.3% of fQRS patients) in precordial leads, and others (23% 
of fQRS patients) in a combination of precordial and limb leads. The 
QRS duration was comparable between individuals with or without 
fQRS (93.5 ± 6.3 and 93.6 ± 6.2 msec, respectively; P = .949). All 
laboratory data and other parameters of ECG were comparable be-
tween groups (Table 1).
When comparing echocardiographic parameters, the LVEF 
was comparable between groups (59.6 ± 2.4% vs 58.9 ± 2.5%, 
P = .310). However, based on 2D-STE, patients with fQRS had sig-
nificantly lower values of apical LV GLS in 2-chamber (16.9 ± 2.5 vs 
20.5 ± 3.3, P < .001), 4-chamber (16.9 ± 3.4 vs 20.1 ± 3, P = .001), 
LAX views (17.7 ± 2.8 vs 20.8 ± 3.5, P = .001), and averaged LV GLS 
(17 ± 2.6 vs 20.4 ± 2.7, P < .001) values compared to individuals 
without fQRS (Figure 1). The number of individuals with abnormal 
LV GLS (defined as <16) was significantly higher in individuals with 
fQRS compared to those without fQRS (23.1% vs 0%, P = .009). In 
addition, there was no significant difference between groups re-
garding the number of individuals with mild LV diastolic dysfunc-
tion (7.7% vs 10.7%, P = .626). Other echocardiographic values are 
summarized in Table 2.
Due to a high number of smokers among individuals with fQRS, 
we compared echocardiographic values among individuals with or 
without fQRS in subgroups by smoking history. All echocardiographic 






(n = 28) P value
Age, year 40.3 ± 10.7 35.4 ± 11.2 .110
Male 21 (80.8%) 17 (60.7%) .107
BMI, kg/m2 26.3 ± 4.7 26.3 ± 3.3 .989
Systolic BP, mm Hg 118.5 ± 10.5 119 ± 9.8 .836
Diastolic BP, mm Hg 70.4 ± 7.3 71 ± 8.6 .793
Smoking 8 (30.8%) 2 (7.1%) .026
Familial history of CVD 4 (15.4%) 1 (3.6%) .135
ECG parameters
Heart rate, bpm 76.5 ± 9.4 78.2 ± 8.8 .493
P duration, ms 85.26 ± 5.8 84.8 ± 6.7 .793
P amplitude, ms 1.9 ± 0.3 2 ± 0.2 .302
PR interval, ms 150.4 ± 23.2 154.6 ± 24.1 .512
QRS duration, ms 93.5 ± 6.3 92.5 ± 7 .599
QTc, ms 393.7 ± 17.9 391.5 ± 21.5 .682
Laboratory parameters
Potassium, mg/dl 4.1 ± 0.4 4.2 ± 0.4 .576
Creatinine, mg/dl 1 ± 0.15 1 ± 0.2 .304
Fasting blood glucose, 
mg/dl
90.3 ± 9.9 90.5 ± 8.4 .951
Cholesterol, mg/dl 178.5 ± 42.1 194.6 ± 27 .105
Triglyceride, mg/dl 219.5 ± 42.3 208.3 ± 28.6 .259
Note: Data are presented as mean ± SD or number (%).
All comparisons are calculated using Chi-squared test or t test.
Abbreviations: BMI, body mass index; BP, blood pressure; bpm, beat per 
minute; CVD, cardiovascular diseases; ECG, electrocardiogram; fQRS, 
fragmented QRS; ms, millisecond; QTc, QT interval corrected for heart rate.
F I G U R E  1   Speckle-tracking echocardiographic parameters in 
patients with or without fragmented QRS
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parameters were comparable between smoker and nonsmokers too 
(data are not reported). When compared individuals with fQRS in less 
than three leads and those with fQRS in more than three leads, the LV 
GLS value was comparable between both groups (data not reported).
In multivariate analysis, averaged LV GLS (OR 0.426, 95% CI 
0.241 - 0.751, P = .003) and smoking history (OR 18.033, 95% CI 
1.086 - 299.404, P = .044) were independent predictors for positive 
fQRS. Other data are summarized in Table 3.
4  | DISCUSSION
In this case-control study, we showed that among apparently healthy 
individuals with normal findings in routine cardiovascular screening 
using a 12-lead standard ECG and a 2D-STE, the LV GLS values were 
significantly lower in individuals with fQRS than those without fQRS. 
Although those with fQRS smoked more than non-fQRS participants, 
there was no significant difference with regard to the echocardio-
graphic parameters between individuals with or without smoking his-
tory. In addition, on multivariate analysis, averaged LV GLS, inversely, 
and smoking, directly, were associated with the presence of fQRS in 
our cohort.
Cardiac magnetic resonance imaging and histopathologic eval-
uations of the myocardium can be used for detecting myocardial 
fibrosis and/or scar;29,30 however, these modalities are invasive 
or expensive for the assessment of cardiac tissue. In contrast, the 
fQRS as a readily available, noninvasive, and low-cost tool may pro-
vide some clues for the evaluation of myocardial scar. Uslu et al12 
retrospectively evaluated individuals with myocardial infarction 
and found that LV wall motion, measured by echocardiography, was 
significantly associated with the presence of fQRS. Das et al4 also 
showed that the fQRS, in the presence of wide QRS complex, was a 
relatively sensitive and highly specific marker for identifying myo-
cardial scar in patients with known or suspected coronary artery 
disease. In addition, in a meta-analysis of 2026 patients with myo-
cardial infarction,31 the fQRS at baseline predicted the develop-
ment of LV dysfunction, major cardiovascular events, and mortality.
The fQRS has also been found to be associated with subtle myo-
cardial dysfunction in several reports. Oner et al32 evaluated patients 
with metabolic syndrome and compared them with matched control 
individuals without metabolic syndrome. They observed that fQRS 
was more common among patients with metabolic syndrome com-
pared to those without it (26.1% vs 14.6%, P = .041). In addition, 
when compared to healthy controls, metabolic syndrome patients 






(n = 28) P value
LVEF, % 59.6 ± 2.4 58.9 ± 2.5 .310
LVEDV, mL 95.6 ± 17.6 87.6 ± 18.2 .109
LVESV, mL 41.2 ± 6.5 38.5 ± 8.2 .192
LVEDD, mm 4.8 ± 0.3 4.7 ± 0.4 .106
IVSD, mm 1 ± 0.1 0.9 ± 0.08 .008
PWD, mm 0.9 ± 0.08 0.85 ± 0.09 .009
LA volume, mL 37.4 ± 8 36.7 ± 8.2 .775
LVH 4 (14.3%) 5 (19.2%) .626
E, cm/s 0.7 ± 0.06 0.7 ± 0.08 .573
A, cm/s 0.5 ± 0.07 0.5 ± 0.09 1
E/A 1.3 ± 0.2 1.3 ± 0.3 .957
e ,́ cm/s 1.1 ± 0.08 1 ± 0.09 .114
E/eʹ 1.2 ± 0.1 1.2 ± 0.1 .393
DT, ms 228.8 ± 21.1 229.6 ± 21.6 .892
RVOT VTI, cm 18.5 ± 1.3 18.5 ± 1.7 .933
LVOT VTI, cm 21.8 ± 1.9 21.9 ± 2.5 .895
Aortic root size, cm 3.2 ± 0.2 3.1 ± 0.3 .266
TR velocity, m/s 2.1 ± 0.2 2.1 ± 0.1 .649
PAP, mm Hg 21 ± 3.1 20.6 ± 2.2 .596
LVDD* 2 (7.7%) 3 (10.7%) .626
GLS 2-chamber, % 16.9 ± 2.5 20.5 ± 3.3 <.001
GLS 4-chamber, % 16.9 ± 3.4 20.1 ± 3 .001
GLS LAX, % 17.7 ± 2.8 20.8 ± 3.5 .001
Averaged GLS, % 17 ± 2.6 20.4 ± 2.7 <.001
Abnormal GLS, 
values < 16
6 (23.1%) 0 (0) .009
Note: Data are presented as mean ± SD or number (%).
All comparisons are calculated using Chi-squared test, t test, or Fisher's 
exact test.
Abbreviations: A, peak late diastolic mitral velocity; DT, deceleration 
time; E, peak early diastolic mitral velocity; e ,́ peak early velocity; GLS, 
global longitudinal strain; IVSD, interventricular septum diameter; LA, 
left atrium; LVDD, left ventricular diastolic dysfunction; LVEDD, left 
ventricular end-diastolic diameter; LVEDV, left ventricular end-diastolic 
volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular 
end-systolic volume; LVOT, left ventricular outflow tract; PAP, 
pulmonary arterial pressure; PWD, posterior wall diameter; RVOT, right 
ventricular outflow tract; VTI, velocity time integral.
*All patients had grade I diastolic dysfunction. 
TA B L E  3   Univariate and multivariate analyses for association 





Averaged GLS 0.525 0.352 - 0.783 .002
Multivariate analysis
Averaged GLS 0.426 0.241 - 0.751 .003
Age 1.055 0.967 - 1.151 .225
Male 0.745 0.104 - 5.346 .769
BMI 1.081 0.886 - 1.319 .445
QRS duration 1.154 0.990 - 1.344 .066
QTc 1.019 0.974 - 1.067 .419
Smoking 18.033 1.086 - 299.404 .044
Total cholesterol 0.989 0.967 - 1.012 .348
Abbreviation: GLS, global longitudinal strain.
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with fQRS had a higher E/e' and lower e' velocity, indicators of dia-
stolic dysfunction, as well as lower isovolumic acceleration, indicating 
subclinical LV systolic dysfunction. In addition, E/e' and isovolumic 
acceleration were independent predictors of fQRS in patients with 
metabolic syndrome. Yan et al17 evaluated 176 patients with coro-
nary artery disease with preserved LVEF (>45%). After examination 
of all patients using 2D-STE, they found that global, middle, and api-
cal LV longitudinal, radial, and circumferential strains and strain rates 
were significantly lower in the fQRS group compared to the non-
fQRS. Adar et al19 evaluated the ventricular functions in patients with 
chronic kidney disease who had a normal LVEF (≥50%). The preva-
lence of fQRS was significantly higher in patients with an abnormal 
Tei index, indicating LV dysfunction, compared to patients with a 
normal Tei index (71% vs 40%). Moreover, those with an abnormal 
Tei index had a lower E/A compared to those with a normal Tei index. 
These findings are in lines with our findings showing the lower levels 
of LV GLS in patients with fQRS, but in a healthy population.
Based on a population-based study in Finland,8 the rate of 
healthy individuals with fQRS was 18.3% (1518 of 8277 individuals 
without known cardiac diseases), and it has been found to be 14.6% 
among a healthy population in a case-control study.32 In contrast, the 
prevalence of fQRS in other population is significantly greater than 
healthy population. The prevalence of fQRS in patients with chronic 
kidney disease with preserved LVEF,19 metabolic syndrome,32 heart 
failure patients requiring resynchronization therapy,13 and diabetes 
mellitus18 was 60%, 26%, 41.5%, and 28%, respectively. In a former 
population-based study, the fQRS in healthy middle-aged individ-
uals was frequent, but it did not affect the occurrence of cardiac 
death, arrhythmic death, and death from any causes during a mean 
of 30 years follow-up.8 However, among individuals with evidences 
of cardiac diseases, the fQRS in lateral leads was associated with ad-
verse events. In addition, in a recently published case-control study, 
Yaman et al33 found that LV GLS, reflecting systolic function, and 
E/A, reflecting diastolic function, were lower in individuals with fQRS 
compared to those without fQRS. Epicardial adipose tissue thickness 
was also significantly increased in fQRS-positive participants.
In our study, the majority of participants were young and all in-
dividuals were healthy without cardiovascular diseases on routine 
screening; however, there was significant subclinical myocardial 
dysfunction in the echocardiographic examination. Similar to Yaman 
et al 33 study, we found that healthy individuals with fQRS had LV 
systolic dysfunction measured by LV GLS, while there was no dif-
ference in LV diastolic dysfunction. We did not follow-up partici-
pants, and so we could not conclude regarding the prognostic value 
of fQRS in the healthy population with or without abnormal LV GLS 
values. On the other hand, in a recently published results of the 
Copenhagen city heart study,34 low-risk general population with a 
decreased GLS at baseline experienced worse outcomes compared 
to those with higher values of LV GLS during a median of 11 years 
follow-up (hazard ratio 1.12; 95% confidence interval 1.08 to 1.17; 
P < .001 per 1% decrease in GLS levels). Moreover, on multivariate 
analysis, this association remained significant even after adjustment 
for other factors; however, gender modified this association, so that 
GLS did not predict outcomes in women rather than men. The pres-
ent study was a case-control study and participants were matched 
by sex and age, so we could not find any effect of sex on our find-
ings. Given previous studies and our study, we believe that it can be 
postulated that among apparently healthy population, the presence 
of fQRS might be considered as a surrogate of subclinical myocar-
dial dysfunction, which can be evaluated by 2D-STE. The impact of 
this association on the outcomes of apparently healthy population 
warrants further large-scale studies to assess whether concomitant 
fQRS and decreased LV GLS in a healthy population are associated 
with worse outcomes at long-term follow-up or not.
4.1 | Study limitations
This study suffers from some shortcomings needed to be addressed 
in future studies. Firstly, it was a case-control study with small sam-
ple size. Secondly, all participants with atypical chest pain were 
categorized as low-risk group and they did not undergo coronary 
angiography, so we could not definitely say that all patients were 
free of coronary artery disease. Thirdly, we performed neither non-
invasive imaging for the evaluation of myocardial scar/fibrosis nor a 
pathologic evaluation of myocardial tissue to show that which patho-
genesis might contribute to such a phenomenon in our population, 
fQRS and lower LV GLS. Finally, we did not follow-up individuals to 
pursue the prognostic value of concomitant fQRS and decreased LV 
GLS in the healthy population. Given these limitations in this study, 
it seems that future studies should focus on these issues.
5  | CONCLUSION
The presence of fQRS on standard 12-lead ECG in the apparently 
healthy population is significantly associated with lower values of LV 
GLS compared to individuals without fQRS, indicating a subclinical 
myocardial dysfunction.
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